Bacillus

Bacillus is a genus of Gram-positive, rod-shaped, endospore-forming bacteria belonging to the phylum Bacillota, comprising over 200 known species that are widely distributed in soil, water, air, and the gastrointestinal tracts of animals, and notable for their metabolic diversity, resilience through spore formation, and significance in medicine, agriculture, and biotechnology.

Characteristics

Cells of Bacillus are typically straight rods, 0.5–2.5 μm in width and 1.0–10 μm in length, arranged singly or in chains. They are motile by peritrichous flagella in most species. The defining feature is the ability to produce highly resistant endospores under adverse environmental conditions such as nutrient depletion, heat, desiccation, and chemical exposure. The spore is formed within the mother cell and contains a dipicolinic acid–calcium complex and a thick spore coat, granting extraordinary longevity and resistance (e.g., Bacillus subtilis spores can survive boiling water for minutes and remain viable for centuries). Most Bacillus species are obligate aerobes or facultative anaerobes, with a strictly aerobic respiratory metabolism. They are catalase-positive and can utilize a wide range of carbon sources, including carbohydrates, amino acids, and hydrocarbons. Optimal growth temperature varies: mesophiles (e.g., B. subtilis) grow at 25–37 °C, while thermophiles (e.g., Bacillus stearothermophilus) can grow at 55–75 °C.

Taxonomy and Phylogeny

The genus Bacillus was first described by Ferdinand Cohn in 1872, making it one of the oldest bacterial genera. Traditionally, the taxonomy was based on morphological and biochemical traits, but molecular phylogenetics (16S rRNA gene sequencing, whole-genome comparisons) has led to extensive reclassification. Many former “Bacillus” species have been reassigned to new genera such as Geobacillus, Paenibacillus, Lysinibacillus, and others. The type species is Bacillus subtilis. The current taxonomic framework places Bacillus within the family Bacillaceae, order Bacillales, class Bacilli. Notable species include the model organism B. subtilis, the insect pathogen Bacillus thuringiensis, the animal and human pathogen Bacillus anthracis, and the food-poisoning agent Bacillus cereus. Several phylogenetic groups (e.g., the B. subtilis group, the B. cereus group) are recognized based on genetic similarity.

Ecology and Habitat

Bacillus species are ubiquitous in soil, where they play vital roles in nutrient cycling—decomposing organic matter, solubilizing phosphate, and fixing nitrogen (certain species). They are also found in freshwater, marine sediments, plant surfaces, and the gut microbiota of insects, mammals, and birds. Some species are psychrophilic, halophilic, or alkaliphilic, thriving in extreme environments such as hot springs, salt lakes, and deep-sea vents. Their spores enable long-term survival and dispersal via wind, water, and animal vectors.

Pathogenic Species and Disease

Three closely related species constitute the “Bacillus cereus group”: B. cereus, B. thuringiensis, and B. anthracis.

• Bacillus anthracis causes anthrax, a zoonotic disease of livestock and humans. Infection occurs via cutaneous, inhalational, or gastrointestinal routes. The pathogenicity is mediated by a capsule (poly-γ-D-glutamic acid) and a tripartite exotoxin (protective antigen, edema factor, lethal factor). Spores can persist in soil for decades; inhalation anthrax has a high mortality rate without early treatment. Penicillin and ciprofloxacin are common therapies. B. anthracis is classified as a Category A bioterrorism agent.
• Bacillus cereus is a common cause of foodborne illness, producing two types of toxins: heat-stable emetic toxin (cereulide) causing vomiting, and heat-labile diarrheal enterotoxins causing diarrhea. It is also an opportunistic pathogen associated with wound infections, endophthalmitis, and bacteremia in immunocompromised patients.
• Bacillus thuringiensis is primarily an entomopathogen, producing δ-endotoxins (Cry proteins) that are toxic to insect larvae, making it a widely used biological pesticide. It is generally considered non-pathogenic to humans, though rare cases of infection have been reported.

Other rarely pathogenic species include Bacillus mycoides and Bacillus licheniformis.

Industrial and Biotechnological Applications

Bacillus species are exploited in diverse industries due to their efficient protein secretion and metabolic pathways.

• Enzyme production: B. subtilis and related species are major sources of industrial enzymes such as α-amylases, proteases (e.g., subtilisin), cellulases, and lipases. These enzymes are used in detergents, textiles, baking, brewing, and animal feed.
• Antibiotics and antimicrobials: Bacillus produces various peptide antibiotics (e.g., bacitracin, polymyxin, gramicidin S, and surfactin). Bacitracin is used topically; it inhibits cell wall synthesis. Polymyxins have activity against Gram-negative bacteria. Surfactin is a lipopeptide with surfactant and antiviral properties.
• Probiotics: Certain Bacillus spores (e.g., B. subtilis, Bacillus coagulans) are incorporated into dietary supplements and animal feed, surviving gastric passage to colonize the gut and inhibit pathogens.
• Biocontrol and agriculture: B. thuringiensis formulations are used as microbial insecticides. Bacillus subtilis and Bacillus amyloliquefaciens promote plant growth, suppress soilborne pathogens (via antibiotic production and induced systemic resistance), and enhance nutrient availability.
• Bioremediation: Their versatile catabolic capabilities allow degradation of hydrocarbons, pesticides, heavy metals, and synthetic polymers. For example, Bacillus species have been studied for removal of lead, cadmium, and oil spills.
• Heterologous protein expression: B. subtilis is a Gram-positive alternative to Escherichia coli for production of recombinant proteins, due to its ability to secrete proteins directly into the medium.

Research Significance

Bacillus subtilis stands as one of the best-studied bacterial model organisms, central to understanding sporulation, competence (natural genetic transformation), biofilm formation, cell division, and stress responses. The complete genome of B. subtilis strain 168 (4.2 Mb, ~4,200 genes) was sequenced in 1997, providing foundational insights into Gram-positive biology. Its tractability in genetic manipulation (e.g., auxotrophic mutants, reporter fusions) and its industrial relevance continue to make Bacillus a key subject in molecular biology, synthetic biology, and microbial engineering.

Safety and Laboratory Handling

The majority of Bacillus species are non-pathogenic and classified as Risk Group 1 (e.g., B. subtilis). However, B. anthracis is Risk Group 3 and requires Biosafety Level 3 facilities. B. cereus is Risk Group 2. Standard precautions include avoidance of spore inhalation and contamination of surfaces, since spores are heat- and chemical-resistant. Autoclaving (121 °C, 20 min) is required for complete sterilization. Some strains are used as surrogate organisms for anthrax research due to their similarity but lower pathogenicity.